We measured the changes in pial arteriolar di ameter and CSF concentrations of adenosine, inosine, and hypoxanthine during hypoxia in the absence and presence of topically applied dipyridamole (10-6 M) and erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA; 10-5 M). Closed cranial windows were implanted in halothane anesthetized adult male Sprague-Dawley rats for the ob servation of the pial circulation and collection of CSF. The mean resting arteriolar diameter in mock CSF was 31.2 ± 5.9 fLm. Topically applied dipyridamole and EHNA, in combination, caused a slight but significant (p < 0.05) increase in resting arteriolar diameter (33.8 ± 4.3 fLm). With mock CSF, moderate hypoxia caused a 22. 1 ± 9.7% increase in pial vessel diameter. Topically applied dipyridamole and EHNA significantly (p < 0.0 1) poten tiated pial arteriolar vasodilation in response to hypoxia. Moreover, the potentiating effects of dipyridamole and
The purine nucleoside adenosine is a potent va sodilator in many vascular beds and may be in volved in the regulation of cerebral blood flow (CBF) (Berne et aI., 1974; Winn et aI., 1981a) . The adenosine concentration, in brain, correlates tem porally with changes in cerebrovascular resistance during hypoxia, seizures, and ischemia (Winn et aI., 1979 (Winn et aI., ,1980a (Winn et aI., ,1981b . Following its release into the extracellular space, adenosine acts on specific cell surface receptors (Olsson et aI., 1976; Fredholm and Hedqvist, 1980) . The adenosine receptor antag onist, theophylline, inhibits adenosine-induced va sodilation of pial arterioles and attenuates pial arte riolar as well as CBF responses to hypoxia (Morii et aI., 1987) .
EHNA during hypoxia were completely abolished by the ophylline (0.20 fLmollg, i.p.; p < 0.05), an adenosine re ceptor antagonist. Resting concentrations of adenosine, inosine, and hypoxanthine in the subwindow CSF were 0.18 ± 0.09, 0.35 ± 0.2 1, and 0.62 ± 0.12 fLM, respec tively. In the absence of dipyridamole and EHNA, these levels were not affected by sustained moderate hypoxia (Pa02 = 36 ± 6 mm Hg). However, in the presence of dipyridamole and EHNA, the concentration of adenosine in the CSF during hypoxia was significantly (p < 0.05) increased. Our data indicate that dipyridamole and EHNA potentiate hypoxic vasodilation of pial arterioles while simultaneously increasing extracellular adenosine levels, thus supporting the hypothesis that adenosine is involved in the regulation of cerebral blood flow. Key Words: Dipyridamole-Ery thro-9 -(2-hydroxyl -3nonyl)adenine-Hypoxia-Pial arteriolar diameter.
Extracellular adenosine is removed from the in terstitial space by rapid uptake into surrounding cells and subsequent metabolism (Berlin and Ol iver, 1975; Wu and Phillis, 1982) . Thus, adenosine uptake inhibitors such as dipyridamole (Kubler et aI., 1970; Phillis and Wu, 1982) would be expected to potentiate the actions of this nucleoside by in creasing its concentrations in the extracellular space. Moreover, erythro-9-(2-hydroxy-3-nonyl)ad enine (EHNA), an inhibitor of the enzyme adeno sine deaminase, would also potentiate the intersti tial fluid adenosine concentration. Indeed, basal ce rebral interstitial fluid adenosine levels are increased with local infusion of dipyridamole (Park and Gidday, 1990) and EHNA (Sciotti et aI., 1991) . A recent study by Ballarin et ai. (1991) reported an increase in basal interstitial fluid adenosine in the awake rat following infusion of deoxycoformycin, also an adenosine deaminase inhibitor. In addition, systemic administration of dipyridamole (Phillis et aI., 1989) and deoxycoformycin (Phillis et al., 1988) potentiates the release of adenosine into CSF dur-ing hypoxia. In rabbits, intracarotid infusion of dipyridamole causes an increase in CBF and is at tenuated by adenosine deaminase (Heistad and Marcus, 1981) . These previous studies suggest that both uptake and metabolic processes participate in regulating the concentration of adenosine in the ce rebral interstitial space.
The purpose of the present study was to deter mine the effects of topically applied dipyridamole and EHNA on hypoxic vasodilation of pial arteri oles and on CSF concentrations of adenosine and its breakdown products, inosine and hypoxanthine. We utilized the closed cranial window technique in the rat to study the pial circulation and sample CSF.
METHODS

Animal preparation
Adult male Sprague-Dawley rats weighing 350-400 g were initially anesthetized with 1.5-2.0% halothane. The right femoral artery and vein were cannulated for moni toring the blood pressure and intravenous administration of drugs, respectively. The rats were tracheostomized, immobilized with tubocurarine (I mg/kg i.v.), and me chanically ventilated. Halothane was decreased (0.5-1.0%) to maintain a stable arterial blood pressure within the physiologic range. The inspired gases were adjusted to maintain physiologic blood gas tensions. Periodically, small (0.2 ml) amounts of arterial blood were sampled anaerobically for the measurement of pH, Pac02, and Pa02. The rectal temperature was maintained at 37°C by an electrical heating mat. A cranial window was mounted over the right parietal cortex using the methods of Morii et al. (1986) . The artificial CSF, bubbled in 6% CO2, 10% 02' and the balance N2, had the following composition: Na + , 156.5 mEq/L; K + , 2.95 mEq/L; Ca 2 + , 2.50 mEq/L; Mg 2 + , 1.33 mEq/L; HC03 -, 24.6 mEq/L; dextrose, 66.5 mg/dl; and urea, 40.2 mg/dl. The osmolarity of the CSF was 298 mOsm/L. An intracranial pressure (ICP) of 3-5 mm Hg was maintained by adjusting the fluid level of the outflow tube. Pial arterioles on the brain surface were visualized through a video microscope system and the vessel diameter was measured using a video micrometer. CSF samples were collected from the cranial window as previously described (Meno et aI., 199 1) . All samples were stored in a -70°C freezer to be analyzed at a later date by high-performance liquid chromatography (HPLC).
Hypoxia was achieved using a two respirator technique as previously described (Winn et aI., 1981b; Morii et aI., 1987) . A trace of CO2 was added to the hypoxic gas mix ture to maintain the P ac02 within the physiologic range. Because an alteration in blood pressure can result in changes in pial arteriolar diameter, we sought to maintain the blood pressure. We have previously demonstrated (Morii et aI., 1987) that with halothane anesthesia (0.5-1.0%) and a trace of CO2 in hypoxic gases, mild hypoxia does not cause significant changes in the MABP. In con trast, severe hypoxia (P a02 < 35 mm Hg) results in hy potension. In the present study, during hypoxia, we at tempted to maintain the P a02 greater than 35 mm Hg and the blood pressure stable. Animals that developed hy potension (n = 3) during hypoxia were consequently dis carded.
Stock solutions of dipyridamole (10 mM) and EHNA (1 mM) were prepared separately in 100% and 1 % ethanol, respectively. The stock solutions were diluted in mock CSF to make the following solutions: dipyridamole, 0.10, 1, and 10 ILM; EHNA, 10 ILM; and a combination of di pyridamole (l1LM) and EHNA (10 ILM). Our preliminary studies indicate that an ethanol concentration of 0.0 1 % or less has no effect on the pial circulation ( Table O. CSF concentrations of adenosine, inosine,
and hypoxanthine
Hypoxic release of adenosine, inosine, and hypoxan thine was determined in five separate groups of animals: (a) topically applied dipyridamole (0. 1 ILM; n = 5), (b) dipyridamole (I ILM; n = 5), (c) dipyridamole (10 ILM; n = 4), (d) EHNA alone (10 ILM; n = 5), and (e) dipyrid amole (l1LM) and EHNA ( 10 ILM) in combination (n = 9). We utilized a sampling technique previously described for subwindow CSF analysis (Meno et aI., 1991) . In brief, mock CSF was perfused for 5 min to wash out the space under the window, and then the perfusion pump was stopped and the CSF was allowed to equilibrate for 20 min. Normoxic CSF was then sampled by perfusing mock CSF (0.25 ml/min) for 30 s while collecting the displaced fluid at the outflow port. Another 5 min of perfusion and 20 min of equilibration was allowed prior to the hypoxic episode. Moderate hypoxia was induced for 20 min before CSF was collected. Following the hypoxic episode, the animals were allowed to recover for 5-10 min until pre hypoxia blood gases were restored. The above procedure was repeated following topical application of CSF con taining either dipyridamole, EHNA, or dipyridamole and EHNA.
Effect of dipyridamole and EHNA on pial vasodilation during normoxia and hypoxia
The pial arteriolar diameter was measured prior to and following 2 min of moderate hypoxia. A small amount of blood was sampled during the hypoxic episode, immedi ately following vessel diameter measurement, to deter mine hypoxic blood gases. The animals were then al lowed to recover from the hypoxic episode (5-10 min) until prehypoxia blood gases and the vessel diameter were restored. The above procedure was repeated follow ing topical application of dipyridamole and EHNA in combination. A second recovery period (5-10 min) was allowed to restore blood gases and the vessel diameter to control values. The animals were then given theophylline (0.20 ILmoUg i.p.) and 30 min later SUbjected to another hypoxic insult. It was previously determined that 30 min is required for this dose of theophylline to reach effective concentrations in the CSF (Morii et a!., 1987) .
Analytical procedures
All CSF samples were analyzed for adenosine, inosine, and hypoxanthine using reverse-phase HPLC (Hartwick et a!., 1979) . A Microsorb (CI8, 5 !-lm) column with a 0 to 25% methanol in 20 mM KH2P04 (pH 5.6) linear gradient over 30 min was used to separate compounds of interest. The retention times and peak heights of known standards were used to identify and calculate the concentrations of adenosine, inosine, and hypoxanthine in each sample.
Statistical analysis
Data are expressed as means ± SD. A paired t test was used to make statistical comparisons. When multiple si multaneous comparisons were made, a Bonferroni cor rection was applied. A p value of less than 0.05 was used to indicate statistically significant differences.
RESULTS
CSF adenosine, inosine, and hypoxanthine during hypoxia
Adenine nucleoside and base concentrations dur ing normoxia and hypoxia are shown in Tables 2  and 3 . Endogenous, normoxic concentrations of adenosine, inosine, and hypoxanthine in the sub window space were 0.18 ± 0.03, 0. 35 ± 0.07, and 0.62 ± 0.12 /LM, respectively, and did not change significantly with the addition of dipyridamole alone (Table 2) , EHNA alone (Table 2) , or dipyridamole (1 /LM) and EHNA (10 /LM) in combination (Table  3) . Sustained (20 min) moderate hypoxia (Pao 2 = 35.9 ± 2.3 mm Hg) did not significantly affect the concentrations of these compounds in mock CSF, nor did the addition of dipyridamole alone or EHNA alone affect the concentrations of these sub stances during hypoxia (Tables 2). In contrast, however, with the combination of di pyridamole and EHNA, we observed a 2.14-fold increase in adenosine concentration during hypoxia (Table 3 ). The concentrations of inosine and hypo-xanthine, however, did not increase during hypoxia in the presence of dipyridamole and EHNA. As in dicated in Table 3 , Paco 2 and MABP were success fully maintained during the hypoxic period.
Effect of dipyridamole and EHNA on pial arteriolar diameter during normoxia and hypoxia During normoxia, topical application of dipyri damole and EHNA in combination caused a slight but significant (p < 0.05) increase in pial arteriolar diameter from 31.2 ± 5.9 to 33.8 ± 4.3 /Lm (Table  4 ). The changes in pial arteriolar diameter during moderate hypoxia, in the presence of dipyridamole, are illustrated in Fig. 1 . Dipyridamole and EHNA significantly (p < 0.01) potentiated the hypoxic va sodilation of the pial arterioles (31.2 ± 7.3% vs. 22.1 ± 9.7%). In the same group of animals, theophylline (0.20 /Lmollg i.p.) significantly (p < 0.05) abolished the potentiating effects of dipyridamole and EHN A during hypoxia. Physiologic parameters are shown in Table 4 .
DISCUSSION
In the present study, we utilized the closed cra nial window technique in the rat to study the effects of topically applied dipyridamole and EHNA on the pial arteriolar diameter and on CSF concentrations of adenosine, inosine, and hypoxanthine during nor moxia and hypoxia. In the normoxic state, dipyr idamole and EHNA together caused a slight but significant increase in resting pial vessel diameter. Moreover, vasodilation of pial arterioles in re sponse to hypoxia was significantly potentiated fol lowing topical application of these agents. In the same animals, theophylline abolished the effects of dipyridamole and EHNA during hypoxia. When di pyridamole and EHNA were topically applied, we observed a significant increase in CSF concentra tions of adenosine during hypoxia. Values are means ± SO. Adenosine, inosine, and hypoxanthine values expressed as fLM. 
Control
Adenosine has been proposed as a metabolic reg ulator of CBF (Berne et al. , 1974; Winn et al. , 1981a) . Several studies have been published docu menting increases in adenosine concentration in brain, interstitial fluid, and CSF under conditions in which oxygen supply to the brain is decreased (Winn et al., 1981b; Van Wylen et al., 1986; Phillis et al. , 1987) . Moreover, adenosine receptor antag onists and uptake inhibitors have been utilized ex tensively in studies attempting to define the role of this nucleoside in blood flow regulation (Ko et al. , 1990; Morii et al. , 1987; Park and Gidda y, 1990; Phillis et al., 1989) .
Dipyridamole is capable of a variety of other ac tions in addition to its inhibition of the nucleoside transport system. For example, dipyridamole inhib its cyclic AMP phosphodiesterase (Afonso and O'Brien, 1971; Phillis and Wu, 1982) , prostacylin formation (Blass et al. , 1980) , and adenosine deam inase (Afonso and O'Brien, 1971; Phillis and Wu, 1982) . However, these actions of dipyridamole, however, require concentrations greater than was utilized in our experiments (Boeynaems et al. , 1986; Phillis and Wu, 1982) . Moreover, perfusion of dipyridamole (10-6 M) into the window did not sig nificantly affect the resting vessel diameter. This is consistent with previous studies in which the same concentration of dipyridamole was topically applied (Ibayashi et al., 1988; Ko et al. , 1990) . The concentration of EHNA utilized in the pre sent study was approximately 2,000 times the Ki for adenosine deaminase (Agarwal, 1982) . Achterberg et al. (1985) reported 92% inhibition of adenosine deaminase activity in the heart using similar con centrations (50 flM) of EHNA. It is difficult to com pare the concentration of EHNA utilized in the pre sent study with previous reports on adenosine re lease into brain extracellular fluid, as EHNA was administered systemically (Zetterstrom et al., 1982) and the concentration of EHNA in the brain was not reported. However, recently, a higher concen tration (1 mM) of EHNA, administered via a dialy sis cannula, was shown to increase the basal inter stitial fluid adenosine levels and CBF (Sciotti et al., 1991) .
Changes in pial arteriolar diameter
During hypoxia, dipyridamole and EHNA, to gether, potentiated pial arteriolar vasodilation. Fol lowing pretreatment with theophylline, and in the presence of dipyridamole and EHNA, the vessels still dilated in response to hypoxia but the potenti ating effect of dipyridamole and EHNA was absent. Our previous studies (Morii et al., 1987) have shown greater attenuation of hypoxic vasodilation by theophylline in the absence of adenosine enhancing agents (i. e., dipyridamole and EHNA). Moreover, other studies (Wahl and Kuschinsky, Values are means ± SD (n = 6). DPM = dipyridamole (10-6 M); EHNA = erythro-9-(2-hydroxy-3-nonyl)adenine (10-5 M); THEO = theophylline (0. 20 fJ,mol/g, i. p. ). Q P < 0. 05 compared to corresponding CSF value. 1976) have reported that a 500-fold greater concen tration of theophylline (compared to adenosine) is required to inhibit the vasodilator effect of adeno sine. Thus, the ability of theophylline to block the actions of adenosine depends on both the concen tration of theophylline and the concentration of adenosine.
The results of present pial arteriolar observations suggest that the potentiating effect of dipyridamole and EHN A is due to increased extracellular aden osine levels. The measured increase in CSF concen tration of adenosine, in the presence of these agents, confirms this. Thus, it is likely that the higher concentration of adenosine in the perivascu lar space during hypoxia, in the presence of dipy ridamole and EHNA, requires a greater concentra tion of theophylline to produce a similar amount of inhibition to that reported by Morii et ai. (1987) .
Changes in CSF adenosine concentrations
The normoxic CSF adenosine concentration was 0.18 ± 0.09 f.LM, while inosine and hypoxanthine were 0.35 ± 0.21 and 0.62 ± 0.12 J.LM, respectively. These concentrations are consistent with our previ ously published values using the cranial window technique in the rat (Meno et aI., 1991) . Dipyri-dam ole alone, EHNA alone, or dipyridamole and EHNA in combination did not affect the resting lev els of these compounds. However, as noted above, the combination of dipyridamole and EHN A did af fect the normoxic diameter of pial arterioles. De spite these changes in pial diameter, we were un able to measure significant changes in CSF concen tration of adenosine during normoxia, Our failure to demonstrate an increase in CSF concentration of adenosine under these circumstances (i.e., nor moxia and in the presence of dipyridamole and EHNA) may be related to the relatively large vol ume of fluid in the subwindow compartment and the consequent dilution of the perivascular concentra tion of adenosine. Alternatively, dipyridamole and EHNA might be affecting the pial arteriolar diame ter directly or by non-adenosine mechanism(s). However, as outlined above, these latter possibili ties seem unlikely in view of the concentrations of dipyridamole and EHNA utilized in the present study. Moreover, Phillis et ai. (1989) reported that dipyridamole (500 f.Lg/kg i. v.) did not cause an in crease in basal adenosine, inosine, and hypoxan thine concentrations of the cortical cup. Our obser vations are in agreement with their data but in con trast to the findings of Park and Gidday (1990) in newborn piglets (10-4 M), and Ballarin et ai. (1991) in rats (10-5 M), where dipyridamole increased resting dialysate concentrations of adenosine. The different methods of administration and concentra tions of dipyridamole used may explain the differ ences between our results and those from the study of Park and Gidday (1990) and Ballarin et ai. (1991) .
. During hypoxia and in the presence of dipyrid amole and EHNA, the CSF adenosine concentra tion was significantly increased. However, in the absence of uptake blockers and adenosine deami nase inhibitors, the concentration of adenosine in CSF was unchanged during hypoxia. This observa tion is in contrast to the findings of Phillis et ai. (1987) using the cortical cup technique. These in vestigators reported a 640% increase in CSF aden osine levels when P a0 2 was dropped to 29 mm Hg. In those experiments, however, the MABP and P aco2 were also allowed to fall to 64 and 25 mm Hg, respectively. The decreases in MABP and P aco2 have both been observed to increase brain and in terstitial fluid adenosine concentrations (Winn et aI., 1980b; Van Wylen et aI., 1988) . In agreement with our data, Park et al (1987) observed no signif icant increase in cisternal CSF adenosine levels in newborn piglet when the Pao2 was decreased to 19.5 mm Hg and the MABP and P aco2 were kept con stant. Moreover, a similar study of Laudignon et ai. (1990) reported no significant increase in the CSF adenosine concentration during hypoxia when the MABP and Paco2 were stable.
Increases in the cerebral adenosine concentration during hypoxia have been reported in the past (Phillis et aI., 1987; Van Wylen et aI., 1986; Winn et aI., 1981b) . Thus, the lack of increase in CSF aden osine during hypoxia, in the present study, is sur prising but can be attributed to differences in meth odologies such as (a) the anatomical site from which samples are obtained (brain tissue, interstitial fluid, or CSF), (b) different methods of sample collection (i.e., freeze-blow, microdialysis, cortical cup, or cranial window), (c) finally, adenosine removal from the interstitial and CSF spaces is complex and multifactorial. Two, if not three, processes appear to be involved: cellular uptake and incorporation to AMP (by means of adenosine kinase) or catabolism to inosine (by means of adenosine deaminase). In addition, extracellular metabolism by adenosine de aminase (especially in rat) may also be playing a role (Franco et aI., 1986) . Blockade of one pathway alone (i.e., uptake with dipyridamole or deamina tion with EHNA) may allow removal of adenosine by the alternative unblocked pathway. Thus, it is possible that adenosine is metabolized before it reaches the CSF, from which our samples are ob tained. As documented in the present study, it was only when we utilized both an uptake (e.g., dipyr idamole) and a breakdown inhibitor (e.g., EHNA) that we detected an increase in subwindow CSF adenosine levels.
In summary, we have demonstrated that hypoxic vasodilation of pial arterioles is potentiated by top ically applied dipyridamole and EHNA in combina tion. Moreover, theophylline blocked the effects of dipyridamole and EHNA. In addition, we observed a significant increase in CSF concentrations of adenosine during hypoxia, in the presence of dipyri damole and EHNA, suggesting that both uptake and breakdown processes of adenosine are of crit ical importance when attempting to determine its release into the CSF.
